AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
M2PHARMA-April 18, 2012-AcelRx Pharmaceuticals names Kim Gaumer as VP, Regulatory Affairs and Quality Assurance (C)2012 M2 COMMUNICATIONS http://www.m2.com
AcelRx Pharmaceuticals Inc (ACRX), a specialIty pharmaceutical company, announced on Tuesday the appointment of Kimberley Gaumer as vice president, Regulatory Affairs and Quality Assurance.
In her new role, Gaumer will lead all global regulatory, quality and compliance activities for AcelRx, including the development and prosecution of regulatory filings for ARX-01, the Sufentanil NanoTab PCA System, currently in Phase 3 clinical trials.
In addition, she will manage regulatory …